Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Notch pathway activation targets AML-initiating cell homeostasis and differentiation

Open access
Lobry, Camille, Ntziachristos, Panagiotis, Ndiaye-Lobry, Delphine, Oh, Philmo, Cimmino, Luisa, Zhu, Nan, Araldi, Elisa, Hu, Wenhuo, Freund, Jacquelyn, Abdel-Wahab, Omar, Ibrahim, Sherif, Skokos, Dimitris, Armstrong, Scott A., Levine, Ross L., Park, Christopher Y., Aifantis, Iannis·2013·Journal of Experimental Medicine

Abstract

Notch signaling pathway activation is known to contribute to the pathogenesis of a spectrum of human malignancies, including T cell leukemia. However, recent studies have implicated the Notch pathway as a tumor suppressor in myeloproliferative neoplasms and several solid tumors. Here we report a novel tumor suppressor role for Notch signaling in acute myeloid leukemia (AML) and demonstrate that Notch pathway activation could represent a therapeutic strategy in this disease. We show that Notch signaling is silenced in human AML samples, as well as in AML-initiating cells in an animal model of the disease. In vivo activation of Notch signaling using genetic Notch gain of function models or in vitro using synthetic Notch ligand induces rapid cell cycle arrest, differentiation, and apoptosis of AML-initiating cells. Moreover, we demonstrate that Notch inactivation cooperates in vivo with loss of the myeloid tumor suppressor Tet2 to induce AML-like disease. These data demonstrate a novel tumor suppressor role for Notch signaling in AML and elucidate the potential therapeutic use of Notch receptor agonists in the treatment of this devastating leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20121484

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 160

Metadata

Authors
Lobry, C., Ntziachristos, P., Ndiaye-Lobry, D., Oh, P., Cimmino, L., Zhu, N., Araldi, E., Hu, W., Freund, J., Abdel-Wahab, O., Ibrahim, S., Skokos, D., Armstrong, S. A., Levine, R. L., Park, C. Y., & Aifantis, I.
Venue
Journal of Experimental Medicine
Published
2013-01-28
Volume
210
Issue
2
Pages
301-319
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2016100326
Cited by
160
References
12
FWCI
14.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Notch pathway activation targets AML-initiating cell homeostasis and differentiation. https://app.cochat.ai/papers/10.1084/jem.20121484
The paper
Lobry, C., Ntziachristos, P., Ndiaye-Lobry, D., Oh, P., Cimmino, L., Zhu, N., Araldi, E., Hu, W., Freund, J., Abdel-Wahab, O., Ibrahim, S., Skokos, D., Armstrong, S. A., Levine, R. L., Park, C. Y., & Aifantis, I. (2013). Notch pathway activation targets AML-initiating cell homeostasis and differentiation. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20121484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.